3 days popular7 days popular1 month popular3 months popular

Hepatitis C infection may fuel heart risk

Results suggest need for vigilant monitoring in those infected with the liver-damaging virus People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble. The findings, described online July 27 in The Journal of Infectious [...]

New drug combination treats hepatitis C patients also infected with HIV

Roughly 20 to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV). Both blood-borne viruses share the same modes of transmission, but many HCV medications currently have significant limitations due to adverse interactions with HIV treatments. Researchers at University of California, San Diego School of [...]

Hepatitis C virus may be much more prevalent than previously believed

The national incidence of hepatitis C virus (HCV) infection may be underreported when current surveillance methods are used, according to an article published in Annals of Internal Medicine. In 2010, the incidence of HCV infection in the United States was estimated to be 17,000 cases annually. The estimate is based on acute HCV cases reported [...]

New hep C treatments cost-effective for some patients, yet may exceed insurers’ willingness to pay

New therapies for hepatitis C virus (HCV) are cost-effective for some patients, but current costs may be higher than U.S. insurers are willing to pay, according to a study published in Annals of Internal Medicine. Recently approved sofosbuvir administered in combination with ribavirin can be used to treat patients with chronic HCV genotype 2 or [...]

Available treatments for hepatitis C virus cost-effective when initiated early

New treatments for hepatitis C virus (HCV) may be highly effective but are associated with substantial costs that may compel clinicians and patients to consider delaying treatment. However, a new study shows that immediate treatment of HCV-infected patients with moderate or advanced liver scarring is cost-effective. Immediate treatment of patients with minimal or no scarring [...]